Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection
- Study Type:
- EXPANDED_ACCESS
- Last Updated:
- 2021-12-15
Conditions
- COVID-19
Interventions
- DRUG
No Results Yet